LinkOPH

LAS VEGAS — ENV515 travoprost XR intracameral implant appeared to be safe when used during cataract removal in patients with glaucoma, according to phase 2a clinical trial findings presented here. “All patients completed the study per protocol with no early discontinuations,” Tom R. Walters, MD, said at the American Academy of Ophthalmology annual meeting. “One hundred percent of implants were safely removed and aqueous humor was sampled for drug level analysis.”

Read more →

LAS VEGAS — SPK-RPE65 treatment may result in rapid postoperative recovery of visual acuity for RPE65-mediated inherited retinal dystrophies, according to a presentation here. Albert M. Maguire, MD, discussed the phase 3 study’s primary and secondary endpoints, and presented additional results for the gene therapy at the American Academy of Ophthalmology annual meeting.

Read more →

LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Lisa C. Olmos de Koo, MD, MBA, reports 3-year safety and functionality results of implantation of the Argus II retinal prosthesis device (Second Sight) and gives an update on implantation of the second generation of the device.

Read more →

NYU Langone Medical Center held a press conference today to announce the successful completion of the most extensive face transplant to date, which took 26 hours and involved more than 100 staff members.The recipient was retired volunteer firefighter P…

Read more →